IncellDX Long COVID Research Update - Dr Bruce Patterson

IncellDX Long COVID Research Update - Dr Bruce Patterson IncellDX Long COVID (PASC) Research Video with Dr Bruce Patterson | Covid Long Haulers Our recent research on long COVID (PASC) has identified persistent S1 spike proteins from SARS-CoV2 proteins in an immune cell called monocytes. These monocytes act like “garbage trucks,” picking up anything foreign to the body, including viral particles. These monocytes travel all over the body, crossing the blood-brain barrier and inflaming endothelial cells that line your blood vessels. As the monocytes with COVID proteins migrate and irritate these blood vessels, they release pro-inflammatory cytokines and chemokines to signal more inflammation. One of these chemokines is called CCL5 or RANTES and is secreted by both the immune and endothelial cells. Another is FRACTALKINE, which acts like velcro, causing the monocytes to stick to endothelial cells. This process is similar to bees and honey, where RANTES acts as honey, and these monocytes with COVID proteins are like bees drawn to the honey. The IncellKINE test that we have developed picks up these immune signals and telegraphs us to the underlying cause of many of your symptoms. So, our treatment goals are to prevent these monocytes from migrating to various parts of the body by blocking the effects of RANTES and immunomodulating the effects of the other cytokines. We use an armamentarium of medications that target specific cytokines unique to your immune profile. Most importantly, we can now measure your response to these medications using our patented long hauler index to guide your clinical management. Our Papers: 1. https://www.frontiersin.org/articles/... 2. https://www.biorxiv.org/content/10.11... Website to learn more and register: www.covidlonghaulers.com